P. Myles

First name
P.
Last name
Myles
Persson, R., Hagberg, K. W., Vasilakis-Scaramozza, C., Yelland, E., Williams, T., Myles, P., & Jick, S. S. (2022). Presence of Codes for Indication for Use in Clinical Practice Research Datalink Aurum: An Assessment of Benign Prostatic Hyperplasia Treatments. Clin Epidemiol, 14, 641-652. http://doi.org/10.2147/clep.s360843
View
Haroon, S., Nirantharakumar, K., Hughes, S. E., Subramanian, A., Aiyegbusi, O. L., Davies, E. H., et al. (2022). Therapies for Long COVID in non-hospitalised individuals: from symptoms, patient-reported outcomes and immunology to targeted therapies (The TLC Study). Bmj Open, 12, e060413. http://doi.org/10.1136/bmjopen-2021-060413
View
Venkatesan, S., Okoli, G. N., Mozid, A. M., Pickworth, T. W., Grocott, M. P., Sanders, R. D., & Myles, P. (2016). Effects of five preoperative cardiovascular drugs on mortality after coronary artery bypass surgery: A retrospective analysis of an observational study of 16, 192 patients. Eur J Anaesthesiol. http://doi.org/10.1097/eja.0000000000000340
View
Ghosh, R. E., Crellin, E., Beatty, S., Donegan, K., Myles, P., & Williams, R. (2019). How Clinical Practice Research Datalink data are used to support pharmacovigilance. Therapeutic Advances in Drug Safety. http://doi.org/10.1177/2042098619854010
View
Wolf, A., Dedman, D., Campbell, J., Booth, H., Lunn, D., Chapman, J., & Myles, P. (2019). Data resource profile: Clinical Practice Research Datalink (CPRD) Aurum. Int J Epidemiol. http://doi.org/10.1093/ije/dyz034
View
Jick, S. S., Hagberg, K. W., Persson, R., Vasilakis-Scaramozza, C., Williams, T., Crellin, E., & Myles, P. (2020). Quality and completeness of diagnoses recorded in the new CPRD Aurum Database: evaluation of pulmonary embolism. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.4996
View
Persson, R., Vasilakis-Scaramozza, C., Hagberg, K. W., Sponholtz, T., Williams, T., Myles, P., & Jick, S. S. (2020). CPRD Aurum database: Assessment of data quality and completeness of three important comorbidities. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.5135
View
Khan, N. F., Booth, H. P., Myles, P., Mullett, D., Gallagher, A., Evans, C., et al. (2021). Use of prescribing safety quality improvement reports in UK general practices: a qualitative assessment. BMC Health Serv Res. http://doi.org/10.1186/s12913-021-06417-0
View
Flynn, R., Hedenmalm, K., Murray-Thomas, T., Pacurariu, A., Arlett, P., Shepherd, H., et al. (2020). Ability of primary care health databases to assess medicinal products discussed by the European Union Pharmacovigilance Risk Assessment Committee. Clin Pharmacol Ther. http://doi.org/10.1002/cpt.1775
View
Persson, R., Sponholtz, T., Vasilakis-Scaramozza, C., Hagberg, K. W., Williams, T., Kotecha, D., et al. (2021). Quality and Completeness of Myocardial Infarction Recording in Clinical Practice Research Datalink Aurum. Clin Epidemiol. http://doi.org/10.2147/clep.s319245
View